HCA Healthcare (HCA) expects to mitigate a significant portion of headwinds from changing US healthcare policies through its ongoing resiliency initiatives, RBC Capital Markets said in a Monday note.
The headwinds relate to new work requirements and changes to Medicaid supplemental state-directed payments under the One Big Beautiful Bill Act, which still awaits broader Senate approval, the investment firm said.
According to RBC, HCA Healthcare considers the House's version of the bill "far more favorable" than the Senate Finance Committee's from a Medicaid funding standpoint. While the company has not quantified the potential financial impact, RBC noted that the Senate version offers more favorable provisions for state-based exchanges.
The brokerage said it came away "incrementally more confident" in HCA's positioning ahead of potential policy changes, citing progress in the company's resiliency program.
The initiatives have mostly focused on labor, the company's largest cost, but HCA is also expanding artificial intelligence use cases to drive operational efficiency, including staffing optimization and supply chain management.
RBC raised its price target on HCA Healthcare to $404 from $376 while maintaining an outperform rating.
Price: 380.30, Change: +2.80, Percent Change: +0.74
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。